@incollection{,
	
					
					
					842FA2B2156F08F65D1FA9C93F8FA103
				,
	author={{Dr. SatinderKaur} and {PGI chandigarh}},
	journal={{Global Journal of Medical Research}},
	journal={{GJMR}}2249-46180975-588810.34257/GJMR,
	address={Cambridge, United States},
	publisher={Global Journals Organisation}12679
}

@incollection{b0,
	
	
		,
	title={{Population based assessment of diabetic retinopathy in an urban population in South India}}
		,
	author={{
			LDandona
		} and {
			RDandona
		} and {
			TJNaduvilath
		} and {
			CAMccarty
		} and {
			GNRao
		}}
		
		
		
		
	
	
		,
	journal={{Br J Ophthalmol}}
		
			8
			
			,
	year={1999}
		
	

}

@incollection{b1,
	
	
		,
	title={{Biochemistry and molecular cell biology of diabetic complications}}
		,
	author={{
			MBrownlee
		}}
	
	
		,
	journal={{Atherosclerosis}}
		
			
			,
	year={2001. 2006}
		
	
	,
	note={Nature}

}

@incollection{b2,
	
	
		,
	title={{C-reactive protein reassessed. New Engl}}
		,
	author={{
			AlanRTall
		} and {
			MB
		}}
		
	
	
		,
	journal={{J. Med}}
		
			
			,
	year={2004}
		
	

}

@incollection{b3,
	
	
		,
	title={{Mechanism of diabetic vasculopathy; An overview}}
		,
	author={{
			MCooper
		} and {
			FBonnet
		} and {
			MOldfield
		} and {
			KJandeleit
		}}
		
		
		
	
	
		,
	journal={{Am. J. Hypertension}}
		
			
			,
	year={2001}
		
	

}

@incollection{b4,
	
	
		,
	title={{High serum Lp(a) levels in Korean Type 2 diabetes patients with proliferative diabetic retinopathy}}
		,
	author={{
			CHKim
		} and {
			HJPark
		} and {
			JYPark
		} and {
			SKHong
		} and {
			YHYoon
		} and {
			KULee
		}}
		
		
		
		
		
	
	
		,
	journal={{Diabetes Care}}
		
			2
			
			,
	year={1998}
		
	

}

@incollection{b5,
	
	
		,
	title={{Association between acute phase reactants and advanced glycation end products in type 2 diabetes}}
		,
	author={{
			CBKathryn
		} and {
			CWing-Sun
		} and {
			BSidney
		} and {
			JohnBRichard
		}}
		
		
		
	
	
		,
	journal={{Diabetes Care}}
		
			27
			
			,
	year={2004}
		
	

}

@book{b6,
	
	
		,
	title={{Significance of serum ceruloplasmin levels in pathological course of diabetic retinopathy}}
		
		
	
	,
	note={Tao Yu-bin}

}

@incollection{b7,
	
	
		,
	title={{Hyperglycemia is a factor for an increase in serum ceruloplasmin in type 2 Diabetes}}
		,
	author={{
			DMakoto
		} and {
			SShinji
		} and {
			YKeiichi
		} and {
			HManaka
		} and {
			HKioko
		} and {
			KMamoru
		}}
		
		
		
		
		
	
	
		,
	journal={{Diabetes Care}}
		
			9
			
			,
	year={1998}
		
	

}

@incollection{b8,
	
	
		,
	title={{Antioxidant potential, paraoxonase 1, ceruloplasmin activity and C eactive protein concentration in diabetic retinopathy}}
		,
	author={{
			MNowak
		} and {
			TWeilkoszynski
		} and {
			BMarek
		} and {
			BKos-Kudta
		} and {
			ESwietochowska
		} and {
			LSieminska
		}}
		
		
		
		
		
	
	
		,
	journal={{Clinical and Experimental Medicine}}
		
			3
			
			,
	year={2009}
		
	

}

@incollection{b9,
	
	
		,
	title={{Evaluation of plasma endothelein-1 and serum inflammatory markers in Patients with diabetic Retinopathy}}
		,
	author={{
			SJManal
		} and {
			NirvanaMostafa
		} and {
			MieSamy
		} and {
			Afify
		}}
		
		
		
	
	
		,
	journal={{J.Med Sci}}
		
			1
			
			,
	year={2005}
		
	
	,
	note={Maha Hashem and Amr Azeb}

}

@incollection{b10,
	
	
		,
	title={{Influence of acute phase proteins on erythrocyte aggregation}}
		,
	author={{
			GWeng X Cloutier
		} and {
			RBeaulieu
		} and {
			GORoederer
		}}
		
		
	
	
		,
	journal={{Am J Physiol}}
		
			6
			
			,
	year={1996}
		
	

}

@incollection{b11,
	
	
		,
	title={{C-reactive protein: a critical update}}
		,
	author={{
			MBPepys
		} and {
			GMHirschfield
		}}
		
	
	
		,
	journal={{J Clin Inves}}
		
			111
			12
			
			,
	year={2003}
		
	

}

@incollection{b12,
	
	
		,
	title={{A one year cross sectional study of serum C-reactive protein(CRP) levels in patients with diabetic Retinopathy attending department of Ophthalmology}}
		,
	author={{
			KHegde
		} and {
			SKodkany
		} and {
			PShivanand
		} and {
			KManunath
		} and {
			KSSmitha
		} and {
			Ramakrishna
		}}
		
		
		
		
		
	
	
		,
	booktitle={{Kles Hospital and medical research centr E Belgaum}}
				
	

}

@book{b13,
	
	
		,
	title={{}}
		,
	author={{
			Group
		}}
		II 51.1±7.93 10.65±6.75
		
	

}

@book{b14,
	
	
		,
	title={{# Table 2 : Mean ceruloplasmin, haptoglobin & CRP levels in diabetic patients with/without retinopathy & controls}}
				
			I----------------
		
	
	,
	note={Group III 58±7.26* 13.9±7.19# group III VS controls}

}